Quest provides US-managed services in Taiwan
US-base firm Quest Pharmaceutical Services (QPS) has announced that its Taiwan testing facility can now provide bioanalytical services managed directly from the US.
Archives for May 15, 2007
RNAi cancer therapies set for clinical testing
The race to put the first cancer therapy based on RNA interference (RNAi) technology into clinical trials has heated up with one developer claiming it is almost ready to go.
Bacterially derived nanocells offer direct route for cancer therapy
Bacterially derived nanocells that can deliver chemotherapeutic drugs directly to cancer cells without the shortcomings of liposomal or viral carriers could be in clinical trials by the end of this year, an Australian biotechnology company says.
R&D outsourcing set to climb
Outsourced pharmaceutical R&D spending is set to increase at twice the expected rate of general R&D expenditure for the next five years, according to new research published this week.
Albemarle moves operations to newly bought DSM plant; cuts staff
US contract manufacturer Albemarle has announced it will move operations of its pilot plant in Ohio to its recently acquired manufacturing facility in Michigan.
Granules India tabletting plant to come onstream in August
Contract manufacturer Granules India is moving towards vertical integration, with a new tabletting facility scheduled to come onstream this August at the company's Gagillapur site near Hyderabad in India.
Lupin beefs up with Symbiotec steroids joint venture
India's Lupin Ltd is ramping up its active pharmaceutical ingredient (API) capability by teaming up with compatriot and corticosteroid specialist Symbiotec Pharmalab Ltd.
EU biosimilars regulations still need 'clarifications'
There are some areas of the European approval system for biosimilars that still need to be clarified, a panel of industry experts said during BIO 2007.